Showing results (1541-1550 of 1,619) with videos related to

Sort By:
Pageof 162
JNCI Cancer Spectrum|July 25, 2020
Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer SurvivorsSarah L Kerns, Chunkit Fung, Sophie D Fossa, et al.
Science Advances|December 13, 2024
Regulation of volume-regulated anion channels alters sensitivity to platinum chemotherapyLily Elizabeth R Feldman, Saswat Mohapatra, Robert T Jones, et al.
Urologic Oncology|November 15, 2017
Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutationsBrandon J Manley, Ed Reznik, Mazyar Ghanaat, et al.
JCO Precision Oncology|September 11, 2020
Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic TargetsMaria I Carlo, Nabeela Khan, Ahmet Zehir, et al.
Stem Cells (Dayton, Ohio)|October 23, 2014
Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotencyRitu Kushwaha, Nirmala Jagadish, Manjunath Kustagi, et al.
European Urology|May 23, 2024
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 TrialKelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.
Cancer|October 21, 2023
Genomic ancestry in kidney cancer: Correlations with clinical and molecular featuresRitesh R Kotecha, Andrea Knezevic, Kanika Arora, et al.
JAAD International|June 5, 2023
National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicineNatalia Pelet Del Toro, Rayan Yahia, Steven R Feldman, et al.
Cancer Medicine|September 13, 2022
Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancerMohammad Shahbazi, Xindi Zhang, Paul C Dinh, et al.
Clinical Genitourinary Cancer|March 15, 2018
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk ScoreDarren R Feldman, Shirin Ardeshir-Rouhani-Fard, Patrick Monahan, et al.
Pageof 162